A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase Ⅱa Clinical Trial for the Effectiveness and Safety of Baicalein Tablets in the Treatment of Improve Other Aspects of Healthy Adult With Influenza Fever

NCT03830684 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: Baicalein Tablets 400mg
DRUG: Baicalein Tablets 600mg
DRUG: blank control 0mg

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.